Cart
sales@molnova.com
HIF-1 inhibitor-4
CAS No. 333357-56-5
HIF-1 inhibitor-4( —— )
Catalog No. M35970 CAS No. 333357-56-5
HIF-1 inhibitor-4 (HIF-1 inhibitor-4) is a HIF-1 inhibitor with IC50 of 560 nM. HIF-1 inhibitor-4 reduces the HIF-1α protein level without affecting its mRNA level.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 62 | Get Quote |
|
| 5MG | 92 | Get Quote |
|
| 10MG | 151 | Get Quote |
|
| 25MG | 296 | Get Quote |
|
| 50MG | 480 | Get Quote |
|
| 100MG | 740 | Get Quote |
|
| 500MG | 1485 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHIF-1 inhibitor-4
-
NoteResearch use only, not for human use.
-
Brief DescriptionHIF-1 inhibitor-4 (HIF-1 inhibitor-4) is a HIF-1 inhibitor with IC50 of 560 nM. HIF-1 inhibitor-4 reduces the HIF-1α protein level without affecting its mRNA level.
-
DescriptionHIF-1 inhibitor-4 is a HIF-1 inhibitor (IC50: 560 nM). HIF-1 inhibitor-4 reduces the HIF-1α protein level without affecting its mRNA level.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetHIF/HIF Prolyl-hydroxylase
-
RecptorHIF
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number333357-56-5
-
Formula Weight422.26
-
Molecular FormulaC18H19IN2O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (59.21 mM; Ultrasonic (<60°C)
-
SMILESIC1=CC=C(NC(=O)C2=CC=C(CN3CCOCC3)C=C2)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Nagao S, et al. Synthesis and structure-activity relationships of novel, potent, orally active hypoxia-inducible factor-1 inhibitors. Bioorg Med Chem. 2014 Oct 1;22(19):5513-29. ?
molnova catalog
related products
-
IDF-11774
IDF-11774 (IDF 11774, IDF11774) is a potent, orally bioavailable HIF-1 inhibitor.
-
Isochlorogenic acid ...
Isochlorogenic acid B has antioxidant activity.
-
TAT-cyclo-CLLFVY
Selective HIF-1 dimerization inhibitor. Blocks protein-protein interaction of recombinant HIF-1α, but not HIF-2α, with HIF-1β (IC50 = 1.3 μM). Inhibits hypoxia-induced HIF-1 activity, and decreases VEGF and CAIX expression in osteosarcoma and breast cancer cells in vitro. Also reduces tubularization of hypoxic HUVECs.
